Free Access to TSR Screeners - Sign Up for Your Nightly Pass
Price to Earning ratio Analysis of Sun Pharma Advanced Resea - Deep Dive


Latest FY PE
Period Ending - Mar-25

-14.02


Very Poor PE
Period Ending - Mar-24
-30.87

Very Poor PE
Growth
54.59 %
Trailing Twelve Months PE
Period Ending - Mar-25

-15.77


Very Poor PE
PE Analysis of Sun Pharma Advanced Resea
P/E Ratio -15.77 of Sun Pharma Advanced Resea is negative because of negative EPS.
PE Ratio of SPARC rose handsomely by 54.59 % this year.
PE Ratio with value of -14.02 was highest in Year Mar-25 in last Five Years.
PE Ratio with value of -38.42 was lowest in Year Mar-22 in last Five Years.
Latest PE Ratio with value of -14.02 is Greater than Average PE of -26.18 in last five years.
Other PE Related Info of SPARC that may interest you.
Sun Pharma Advanced Resea Overview
CodePricePrevious PricePrice ChangeSector
SPARC145.05146.861.23 % Drugs & Pharma
Fundamental AnalysisTechnical Analysis
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued.    more ..
Price to Earning Formula
   PE Screener
PE Related Ratios
PriceToSalesRatioPriceToBookRatioPriceToCashFlowRatio

Tsr Value Index
Poor Value StockScreener
FY - Historical Price to Earning of Sun Pharma Advanced Resea
PeriodMar-25Mar-24Mar-23Mar-22Mar-21Mar-20Mar-19
PE-14.02-30.87-22.93-38.42-24.64-8.09-34.43
Change54.59 %-34.61 %40.30 %-55.93 %-204.47 %76.50 %28.37 %
Price147.91368.30179.35296.95142.1596.45191.10
Price Change-59.84 %105.35 %-39.60 %108.90 %47.38 %-49.53 %-49.36 %
You are view first 7 Records. Log in to view all 20 in Premium view
FY Chart of Price to Earning of Sun Pharma Advanced Resea
Understanding Price to Earning

Value Investing   eBook  

Free PDF eBook on Value Investing

Value Investing  eBook

Free PDF eBook on Value Investing